National Bank Of Canada Maravai Lifesciences Holdings, Inc. Transaction History

National Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$6.87 - $11.34 $1.22 Million - $2.02 Million	-178,000 Reduced 99.96%	70 $0
Q1 2024 May 13, 2024	SELL	$5.11 - $8.76 $132,630 - $227,365	-25,955 Reduced 12.72%	178,070 $1.54 Million
Q4 2023 Feb 06, 2024	BUY	$4.7 - $9.87 $958,729 - $2.01 Million	203,985 Added 509962.5%	204,025 $1.34 Million
Q2 2023 Jul 26, 2023	SELL	$12.09 - $15.0 $5.88 Million - $7.29 Million	-486,293 Reduced 99.99%	40 $0
Q1 2023 Apr 12, 2023	BUY	$12.99 - $16.48 $4.6 Million - $5.84 Million	354,300 Added 268.34%	486,333 $6.81 Million
Q4 2022 Jan 24, 2023	BUY	$12.5 - $24.78 $1.65 Million - $3.27 Million	132,008 Added 528032.0%	132,033 $0
Q4 2021 Jan 24, 2022	BUY	$35.0 - $45.94 $875 - $1,148	25 New	25 $1,000

227

140M

237K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $650M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.